MICROPORT CARDIO.MEDTECH. - Asset Resilience Ratio

Latest as of June 2025: 37.03%

MICROPORT CARDIO.MEDTECH. (72X) has an Asset Resilience Ratio of 37.03% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of MICROPORT CARDIO.MEDTECH. to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€987.89 Million
≈ $1.15 Billion USD Cash + Short-term Investments

Total Assets

€2.67 Billion
≈ $3.12 Billion USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2022–2024)

This chart shows how MICROPORT CARDIO.MEDTECH.'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of MICROPORT CARDIO.MEDTECH..

Liquid Assets Composition Over Time

This chart breaks down MICROPORT CARDIO.MEDTECH.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read debt load of MICROPORT CARDIO.MEDTECH. for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €987.89 Million 37.03%
Total Liquid Assets €987.89 Million 37.03%

Asset Resilience Insights

  • Very High Liquidity: MICROPORT CARDIO.MEDTECH. maintains exceptional liquid asset reserves at 37.03% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

MICROPORT CARDIO.MEDTECH. Industry Peers by Asset Resilience Ratio

Compare MICROPORT CARDIO.MEDTECH.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.84%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 34.37%
Stratec SE
XETRA:SBS
Medical Devices 0.29%
Shinhung
KO:004080
Medical Devices 4.17%
DRTECH Corporation
KQ:214680
Medical Devices 5.18%
Novacyt
PA:ALNOV
Medical Devices 0.02%
Diagnostic Medical Systems SA
PA:ALDMS
Medical Devices 1.48%

Annual Asset Resilience Ratio for MICROPORT CARDIO.MEDTECH. (2022–2024)

The table below shows the annual Asset Resilience Ratio data for MICROPORT CARDIO.MEDTECH..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 46.74% €1.25 Billion
≈ $1.46 Billion
€2.68 Billion
≈ $3.13 Billion
+19.26pp
2023-12-31 27.48% €708.27 Million
≈ $828.04 Million
€2.58 Billion
≈ $3.01 Billion
+20.52pp
2022-12-31 6.96% €208.94 Million
≈ $244.27 Million
€3.00 Billion
≈ $3.51 Billion
--
pp = percentage points

About MICROPORT CARDIO.MEDTECH.

F:72X Germany Medical Devices
Market Cap
$366.87 Million
€313.80 Million EUR
Market Cap Rank
#19023 Global
#1751 in Germany
Share Price
€0.25
Change (1 day)
-23.80%
52-Week Range
€0.08 - €0.42
All Time High
€2.25
About

MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People's Republic of China and internationally. The company engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valv… Read more